Mesalamine Pellet Formulation to Maintain Remission of Mild to Moderate Ulcerative Colitis

NCT00744016 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Granulated mesalamine
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.